The current valuation score of Phio Pharmaceuticals Corp is 7.81, ranking 198 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.74, which is -106.13% below the recent high of 0.05 and -21.65% above the recent low of -0.89.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.